TAP Blocks vs. IV Lidocaine for Kidney Transplants

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Postoperative Pain

In brief

This study will compare continuous intravenous lidocaine against single-injection transversus abdominis plane (TAP) block as a modality for postoperative analgesia in kidney transplant surgery.

Key facts

Study ID

NCT03843879

Run by

Benaroya Research Institute

People needed

124

Starts

2019-04-01

Expected to finish

2021-09-01

Last updated by the study team

2019-07-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Kidney transplant recipient
• >18 years old
• Consent to participate

You may not qualify if…

• <18 years old
• Refusal to participate
• Chronic opioid use
• Seizure disorder
• Allergy to local anesthestics
• Severe hepatic disease

Where it is running

• Virginia Mason Medical Center — Seattle, Washington, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.